Michael S. Diamond

Michael Diamond is a physician-scientist with research interests in virology and immunology and a focus on emerging RNA viruses including flaviviruses, alphaviruses, and coronaviruses. Dr. Diamond’s scientific accomplishments include the discovery of immune sensors that distinguish viral and host RNA, the generation of antibody therapeutics against multiple viruses, the delineation of immune mechanisms of control of viral infections, the identification of novel alphavirus entry receptors and their roles in viral tropism and pathogenesis, and the development and study of mucosal and intramuscular vaccines against SARS-CoV-2. Dr. Diamond was born in the borough of Queens in New York City and received his B.A. from Columbia University and M.D. and Ph.D. (in Cell and Developmental Biology) from Harvard Medical School and Harvard University. He completed his residency in Internal Medicine and fellowship in Infectious Diseases at the University of California, San Francisco and postdoctoral training at the University of California, Berkeley. He started his laboratory in 2001 at Washington University School of Medicine, where he is currently the Herbert S. Gasser Professor of Medicine, Molecular Microbiology, and Pathology & Immunology. In addition to his election to the National Academy of Sciences, he is an elected member of the American Society for Clinical Investigation, the Association of American Physicians, the American Academy of Microbiology, the American Association for the Advancement of Science, the National Academy of Inventors, and the National Academy of Medicine.